loading
Amneal Pharmaceuticals Inc stock is traded at $10.50, with a volume of 735.49K. It is up +1.30% in the last 24 hours and up +7.86% over the past month. Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates through Generic and Specialty Pharma divisions. The company's generics portfolio includes approximately 200 product families marketed in various dosage forms, such as solid oral doses comprising tablets, capsules, and powders; liquids; sterile injectables; nasal sprays; inhalation and respiratory products; ophthalmics; films; transdermal patches; and topicals, as well as soft gel, complex molecule, and drug-device combinations. It is also involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders and parasitic infections; and biosimilar products. In addition, the company offers licensed and owned, niche, and mature branded products, as well as a pipeline of 505(b)(2) products for various therapeutic areas that primarily includes Unithroid for endocrinologists and primary care physicians through a contracted salesforce. Amneal Pharmaceuticals, Inc. has a partnership agreement with MabXience S.L. for the development of Avastin, a biosimilar bevacizumab. The company has operations in North America, Asia, and Europe. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
See More
Previous Close:
$10.36
Open:
$10.4
24h Volume:
735.49K
Relative Volume:
0.47
Market Cap:
$3.30B
Revenue:
$2.68B
Net Income/Loss:
$-184.45M
P/E Ratio:
-15.43
EPS:
-0.6805
Net Cash Flow:
$229.23M
1W Performance:
+1.11%
1M Performance:
+7.86%
6M Performance:
+50.14%
1Y Performance:
+21.19%
1-Day Range:
Value
$10.32
$10.50
1-Week Range:
Value
$10.26
$10.68
52-Week Range:
Value
$6.685
$10.68

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
Name
Amneal Pharmaceuticals Inc
Name
Phone
908-947-3120
Name
Address
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
Employee
5,210
Name
Twitter
@amnealpharma
Name
Next Earnings Date
2025-05-02
Name
Latest SEC Filings
Name
AMRX's Discussions on Twitter

Compare AMRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
10.50 3.25B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.78 63.27B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.32 45.67B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.045 39.27B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.14 23.02B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
450.26 20.66B 3.08B 1.24B 1.07B 25.61

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-06-25 Initiated Goldman Buy
Feb-24-25 Upgrade JP Morgan Neutral → Overweight
Sep-06-24 Upgrade JP Morgan Underweight → Neutral
Apr-07-21 Resumed RBC Capital Mkts Sector Perform
Mar-08-21 Upgrade Goldman Sell → Buy
Dec-14-20 Upgrade Barclays Equal Weight → Overweight
Dec-14-20 Upgrade Guggenheim Neutral → Buy
Jul-27-20 Initiated Goldman Sell
May-12-20 Upgrade Guggenheim Sell → Neutral
Dec-12-19 Downgrade Raymond James Outperform → Mkt Perform
Nov-12-19 Downgrade JP Morgan Neutral → Underweight
Nov-07-19 Downgrade SVB Leerink Outperform → Mkt Perform
Jul-22-19 Upgrade SVB Leerink Mkt Perform → Outperform
Jul-11-19 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jul-08-19 Upgrade Piper Jaffray Neutral → Overweight
Jun-11-19 Initiated Barclays Equal Weight
May-21-19 Upgrade Raymond James Mkt Perform → Strong Buy
Mar-20-19 Initiated SunTrust Buy
Mar-08-19 Downgrade SVB Leerink Outperform → Mkt Perform
Dec-14-18 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-16-18 Downgrade SunTrust Buy → Hold
Aug-13-18 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jul-23-18 Initiated Morgan Stanley Overweight
Jun-22-18 Initiated B. Riley FBR, Inc. Buy
View All

Amneal Pharmaceuticals Inc Stock (AMRX) Latest News

pulisher
11:04 AM

Amneal Pharmaceuticals, Inc. (AMRX) Files BLA for XOLAIR® Biosimilar, Targets Multi-Billion-Dollar Market - MSN

11:04 AM
pulisher
Oct 07, 2025

Amneal Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Yahoo Finance

Oct 07, 2025
pulisher
Oct 07, 2025

Amneal Pharmaceuticals (NASDAQ:AMRX) Increases 6.9% This Week, Taking Three-year Gains to 420% - 富途牛牛

Oct 07, 2025
pulisher
Oct 06, 2025

Amneal Pharmaceuticals Hits New 52-Week High of $10.67 - Markets Mojo

Oct 06, 2025
pulisher
Oct 06, 2025

Will Amneal Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Measuring Amneal Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus - Nasdaq

Oct 06, 2025
pulisher
Oct 06, 2025

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Applying Wyckoff theory to Amneal Pharmaceuticals Inc. stockJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Reversal indicators forming on Amneal Pharmaceuticals Inc. stockEarnings Trend Report & Expert Approved Momentum Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is it time to cut losses on Amneal Pharmaceuticals Inc.Quarterly Portfolio Review & Proven Capital Preservation Methods - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using Python tools to backtest Amneal Pharmaceuticals Inc. strategies2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Sentiment analysis tools applied to Amneal Pharmaceuticals Inc.Portfolio Risk Summary & High Win Rate Trade Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Technical analysis overview for Amneal Pharmaceuticals Inc. stock2025 Price Momentum & Low Risk Entry Point Guides - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to read the order book for Amneal Pharmaceuticals Inc.Trade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will breakout in Amneal Pharmaceuticals Inc. lead to full recoveryGap Down & Comprehensive Market Scan Insights - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Amneal Pharmaceuticals Hits New 52-Week High of $10.43 - Markets Mojo

Oct 04, 2025
pulisher
Oct 03, 2025

What to expect from Amneal Pharmaceuticals Inc. in the next 30 daysQuarterly Market Review & Accurate Buy Signal Notifications - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Amneal Pharmaceuticals Inc. stock cheap compared to fundamentalsEarnings Growth Report & Safe Entry Zone Identification - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based exit strategy for Amneal Pharmaceuticals Inc.Market Volume Summary & Smart Investment Allocation Insights - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about Amneal Pharmaceuticals Inc stockGap Up/Gap Down Analysis & Free Take Advantage Of Momentum - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - sharewise.com

Oct 02, 2025
pulisher
Oct 02, 2025

3 Lesser-Known Healthcare Names With Major Upside in Store - sharewise.com

Oct 02, 2025
pulisher
Oct 02, 2025

3 Lesser-Known Healthcare Names With Major Upside in Store - Investing.com

Oct 02, 2025
pulisher
Oct 01, 2025

Amneal Pharmaceuticals stock hits 52-week high at $10.36 By Investing.com - Investing.com Canada

Oct 01, 2025
pulisher
Oct 01, 2025

Amneal Pharmaceuticals stock hits 52-week high at $10.36 - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 09:03:57 - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Amneal to Report Third Quarter 2025 Results on October 30, 2025 - The Manila Times

Sep 30, 2025
pulisher
Sep 30, 2025

Global Biopharma Amneal Pharmaceuticals Schedules Q3 2025 Financial Results and Investor Conference - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Amneal Files Xolair Biosimilar In US ‘Earlier Than Expected’ - insights.citeline.com

Sep 30, 2025

Amneal Pharmaceuticals Inc Stock (AMRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.43
price down icon 0.12%
$9.975
price down icon 1.63%
drug_manufacturers_specialty_generic RDY
$13.99
price down icon 0.26%
$57.89
price down icon 0.28%
$139.52
price up icon 1.90%
$450.26
price down icon 1.53%
Cap:     |  Volume (24h):